Evanesco Therapeutics, a BridgeBio affiliate, is developing a next-generation monoclonal antibody depleter for transthyretin amyloid cardiomyopathy (ATTR-CM). Its approach is designed to clear amyloid already deposited in the heart, and the program is preparing for IND submission after development candidate nomination. This is a small, fast-moving team with startup autonomy within an established company, where the role will have direct line of sight from preclinical data to clinical strategy and help shape high-impact program decisions. The BD&Ops Director / Sr. Director will serve as an entrepreneurial Business Development & Operations leader for Evanesco Therapeutics. The role owns and shapes scientific, operational, and external-facing aspects of value-driving subsidiaries, including business and scientific plans, strategy, and budgets. It applies molecular biology knowledge to interpret and question scientific strategy while overseeing competitive intelligence, financial modeling, and academic and industry relationships. This is a hybrid role based out of BridgeBio’s San Francisco, California office. BridgeBio offers a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and health benefits. The anticipated California salary range is $220,000–$300,000 USD; the final offer depends on factors including experience, education, location, and interview performance.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree